NIHR has awarded MFT £2,998,433 from 1 April 2024 to develop innovative technology solutions for better diagnosis, treatment, and care for people across our region.
Read more
In the latest Spotlight On blog, Dr Ahmed discusses the breakthrough STEP HFpEF study and the importance of equality, diversity and inclusivity in research, sharing her first-hand experiences of this.
Read more
The UK regulatory authorities have approved the first ever trial of a revolutionary gene therapy for young children diagnosed with Hunter syndrome, a devastating rare lysosomal storage disorder.
Read more
ITV Tyne Tees and Granada Reports recently featured the journey of two-year-old Teddi Shaw, who became the first child in the UK to receive NHS life-saving gene therapy treatment, Libmeldy® at MFT.
Read more
R&I colleagues welcomed James McLaughlin, Chief Executive for Cure Leukaemia, to MFT, as he ran 14 km across Manchester to raise funds for blood cancer research at Manchester Royal Infirmary (MRI).
Read more
Good Morning Britain and ITV Granada Reports featured MFT’s BCAN-RAY (Breast Cancer Risk Assessment in Young Women) study, which is running from The Nightingale Centre at Wythenshawe Hospital.
Read more
A 79-year-old woman is the first global participant to a research study that could help some of the millions of people worldwide living with glaucoma – a leading cause of irreversible blindness.
Read more
Bruntwood SciTech, commenced construction on a £42m, 125,000 sq ft specialist lab and office workspace at the Citylabs cluster to strengthen the internationally significant health innovation campus.
Read more
